RLAY

NASDAQStock

Relay Therapeutics, Inc.

$10.40-0.15 (-1.42%)

52-Week Range

$2.00

$10.80

Key Stats

Market Cap

1.9B

P/E Ratio

—

Dividend Yield

—

Beta

1.62

Volume

1.2M

Avg Volume

3.1M

Performance

+18.14%

+24.41%

+155.45%

YTD

+28.97%

+200.57%

-35.20%

-73.80%

Price Chart

ETF Exposure

RLAY is held by 102 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VIRS	Pacer BioThreat Strategy ETF	0.00%	2,519	$19K	$3.7M	0.70%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	43	$454	$337.7M	0.32%

PreviousPage 3 of 3

About RLAY ETF Exposure

Relay Therapeutics, Inc. (RLAY) is held by 102 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.9B, RLAY is a widely held institutional stock. The stock currently trades at $10.40. Investors can gain exposure to RLAY through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RLAY, sorted by portfolio weight.